Basilea Pharmaceutica AG
SIX:BSLN
Wall Street
Price Targets
BSLN Price Targets Summary
Basilea Pharmaceutica AG
According to Wall Street analysts, the average 1-year price target for
BSLN
is 99.96 CHF
with a low forecast of 69.69 CHF and a high forecast of 126 CHF.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BSLN's stock price target?
Price Target
99.96
CHF
According to Wall Street analysts, the average 1-year price target for
BSLN
is 99.96 CHF
with a low forecast of 69.69 CHF and a high forecast of 126 CHF.
What is Basilea Pharmaceutica AG's Revenue forecast?
Projected CAGR
3%
For the last 13 years the
compound annual growth rate for
Basilea Pharmaceutica AG's revenue is
9%.
The projected
CAGR
for the next 4 years is
3%.
What is Basilea Pharmaceutica AG's Operating Income forecast?
Projected CAGR
-33%
The
compound annual growth rate
of Basilea Pharmaceutica AG's operating income for the next 4 years is
-33%.
What is Basilea Pharmaceutica AG's Net Income forecast?
Projected CAGR
-36%
The
compound annual growth rate
of Basilea Pharmaceutica AG's net income for the next 4 years is
-36%.
